# Dexamethasone in Reducing Oral Pain and Dry Mouth After Surgery in Patients With Oropharyngeal Cancer

> **NCT01748942** · NA · COMPLETED · sponsor: **OHSU Knight Cancer Institute** · enrollment: 76 (actual)

## Conditions studied

- Dysphagia
- Pain
- Stage I Oropharyngeal Squamous Cell Carcinoma
- Stage II Oropharyngeal Squamous Cell Carcinoma
- Stage III Oropharyngeal Squamous Cell Carcinoma

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Dexamethasone
- **OTHER:** Placebo
- **PROCEDURE:** Quality-of-Life Assessment
- **OTHER:** Questionnaire Administration
- **PROCEDURE:** Transoral Robotic Surgery

## Key facts

- **NCT ID:** NCT01748942
- **Lead sponsor:** OHSU Knight Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2016-07
- **Final completion:** 2017-03-29
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2018-06-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01748942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01748942, "Dexamethasone in Reducing Oral Pain and Dry Mouth After Surgery in Patients With Oropharyngeal Cancer". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01748942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*